Related by context. All words. (Click for frequent words.) 71 BRCA1 mutation 71 BRCA mutation 69 atypical hyperplasia 68 BRCA1 mutations 68 breast cancer gene mutation 67 BRCA2 gene mutation 67 BRCA2 mutation 67 mutated BRCA1 67 BRCA1 gene 67 BRCA2 mutations 66 ApoE4 gene 66 BRCA mutations 66 polycystic ovary syndrome PCOS 66 BRCA1 gene mutation 65 BRCA2 gene 64 placental malaria 64 BRCA2 carriers 64 APOE e4 63 breast cancer genes BRCA1 63 BRCA gene mutations 63 Fragile X gene 63 APOE4 63 BRCA2 mutation carriers 63 chlamydial infection 63 BRCA1 63 Uterine cancer 62 Ovary removal 62 genes BRCA1 62 irregular menstrual cycles 62 ε4 62 FGFR2 gene 62 hormone receptor negative 62 colorectal neoplasia 62 ApoE4 62 APOE gene 62 BRCA1 BRCA2 62 endometrial cancers 62 thyroid hormone levels 61 BRCA2 gene mutations 61 estrogen receptor negative 61 epithelial ovarian cancer 61 apolipoprotein E4 61 invasive carcinoma 61 chromosomal disorders 61 anovulatory infertility 61 BRIP1 61 prostate cancer CaP 61 estrogen receptor ER 61 BRCA mutation carriers 61 atypia 61 BRCA2 61 BRAC2 60 deCODE BreastCancer TM 60 chromosomal rearrangement 60 chorioamnionitis 60 lobular involution 60 BRCA2 genetic mutations 60 inherited predisposition 60 KRAS oncogene 60 Li Fraumeni 60 V Leiden 60 APOE ε4 60 uterine ovarian 60 HNPCC 60 oophorectomy 60 endometrial carcinoma 60 ductal breast cancer 60 TGFBR1 * 6A 60 Dr Zorbas 60 gestational diabetes mellitus GDM 60 BRCA2 breast cancer 60 CYP#D# genotype 60 germline mutations 60 ductal cancer 60 familial clustering 60 BRCA1 mutation carriers 60 BRCA genes 60 precancerous cervical 60 gestational diabetes mellitus 60 MTHFR 60 CYP#D# gene 60 APOE allele 60 poorer prognosis 59 MYH9 gene 59 p# mutations 59 preventive mastectomies 59 K ras mutations 59 #q# deletion 59 gene BRCA2 59 carbohydrate intolerance 59 KRAS mutations 59 advanced adenomas 59 CIN2 + 59 advanced adenoma 59 noncarriers 59 breast endometrial 59 polycystic ovarian syndrome PCOS 59 prostate pancreatic 59 GSTM1 gene 59 inherited mutations 59 LQTS 59 lymph node involvement 59 salpingo oophorectomy 59 HER2 overexpression 59 faulty BRCA2 gene 59 ApoE4 allele 59 prenatally diagnosed 59 BARD1 59 BRCA carriers 59 ApoE gene 59 advanced neoplasia 59 CC genotype 59 mutant allele 59 TCF#L# gene 59 primary ovarian insufficiency 59 thrombophilia 59 estrogen metabolites 59 Genetic predisposition 59 Klinefelter syndrome 59 PALB2 59 Adjuvant chemotherapy 59 testicular germ cell 58 peritoneal cancer 58 antenatal depression 58 colorectal adenoma 58 hypothalamic amenorrhea 58 TACI mutations 58 premenopausal breast cancer 58 HER2 receptor 58 deCODE BreastCancer 58 monozygotic twin 58 lobular carcinoma 58 TT genotype 58 CHEK2 58 pre eclamptic 58 abnormal mammogram 58 Hurthle cell 58 deleterious mutation 58 PTPN# 58 shorter telomeres 58 CIN3 58 narcolepsy cataplexy 58 hereditary predisposition 58 fibroids endometriosis 58 abnormal Pap smears 58 benign breast 58 polycystic ovaries 58 testicular tumors 58 lymph node biopsies 58 CCR5 delta# 58 unfavorable prognostic 58 cervical carcinoma 58 Menopausal hormone therapy 58 FGFR2 58 BRCA gene 58 HER2 positive cancers 58 postmenopausal hormones 58 breast carcinoma 58 recurrent UTI 58 MetS 58 APOE4 gene 58 UGT#A# * 58 thyrotropin levels 58 SE alleles 58 postmenopausal breast cancer 58 CDH1 58 ABCB1 58 carotid plaques 58 azoospermia 58 multivariate logistic regression 58 obstructive coronary artery 58 recurrent miscarriages 58 chromosomal alterations 58 polycystic ovary syndrome 58 nodal metastasis 58 mtDNA mutations 58 bronchopulmonary dysplasia BPD 58 ADPKD 58 lobular breast cancer 58 HNSCC 57 chromosomal aberrations 57 PTEN gene 57 lung adenocarcinoma 57 Radical prostatectomy 57 ovarian hormones 57 endometrial hyperplasia 57 G allele 57 abnormal pap smears 57 APOE genotype 57 MTHFR gene 57 MGUS 57 MLH1 57 ERBB2 57 adnexal mass 57 placental function 57 PTEN mutations 57 contralateral breast cancer 57 HER2 expression 57 precursor lesions 57 ovulatory cycles 57 familial pancreatic cancer 57 BRCA 57 Polycystic Ovarian Syndrome PCOS 57 ovarian endometrial 57 AML MDS 57 tumor histology 57 APOE e4 gene 57 TP# mutation 57 subclinical hyperthyroidism 57 ovarian malignancy 57 fibrocystic disease 57 lupus anticoagulant 57 p# mutation 57 Ectopic pregnancy 57 adenomatous polyps 57 SLNB 57 G#S mutation 57 penetrance 57 preeclamptic 57 LPA gene 57 hormone deprivation 57 IgA deficiency 57 LRAT 57 coinfection 57 prophylactic mastectomy 57 bilateral oophorectomy 57 genetic syndromes 57 albumin excretion 57 MnSOD 57 Heavy menstrual bleeding 57 pituitary hormone 57 pelvic girdle pain 57 testosterone supplementation 57 progesterone receptor negative 57 apolipoprotein E 57 2D 4D ratio 57 NNRTI resistance 57 gene APOE 57 GISTs 57 endogenous estrogen 57 neural tube defect 57 BRAF mutation 57 AVODART 57 operable breast cancer 57 HCV antibody 56 untreated celiac disease 56 hereditary breast cancer 56 Trichomonas vaginalis 56 TCF#L# 56 mutated gene 56 subclinical hypothyroidism 56 Folate deficiency 56 variant alleles 56 STAT4 56 Bacterial vaginosis 56 Colon polyps 56 K ras gene 56 parous women 56 estrogen deficiency 56 breast cancer subtypes 56 congenital adrenal hyperplasia CAH 56 HER2 positive tumors 56 hepatitis B infection 56 recurrent ovarian 56 ApoE 56 irregular menstrual periods 56 gynecologic malignancy 56 undergo prostate biopsy 56 Chlamydia infection 56 varicoceles 56 RhD negative 56 placenta praevia 56 subclinical atherosclerosis 56 invasive lobular 56 CDKN2A 56 postnatally 56 anovulation 56 MSH2 56 C#Y 56 SHBG levels 56 endometrial thickness 56 abnormal Pap test 56 delaying childbirth 56 dopamine receptor gene 56 premutation 56 axillary node 56 apoE4 56 KIF6 gene 56 BRAF gene 56 GSTT1 56 endogenous hormones 56 undergone hysterectomy 56 lobular cancer 56 precancerous polyp 56 recessive inheritance 56 CAG repeats 56 mammographic density 56 pCR 56 neurodevelopmental outcomes 56 Hashimoto thyroiditis 56 malignant ovarian 56 myeloid leukemia 56 invasive secretory carcinoma 56 gallstone disease 56 recurrent miscarriage 56 genital tract infections 56 androgen deprivation 56 cervical lesions 56 CagA 56 aneuploidy 56 nonmelanoma skin cancers 56 GPC5 56 Endometrial cancer 56 singleton pregnancy 56 apolipoprotein E gene 56 hormone therapy estrogen 56 elevated CRP 56 elevated triglyceride levels 56 diffuse gastric 56 mitochondrial mutations 56 CHD CVD 56 hyperemesis 56 abnormal vaginal bleeding 56 nonalcoholic steatohepatitis NASH 56 thyroid stimulating hormone TSH 56 urothelial carcinoma 56 SOD2 gene 56 hereditary hemochromatosis 56 premature menopause 56 ASCUS 56 Multivariate analyzes 56 Chronic pancreatitis 56 nonpregnant women 56 promoter hypermethylation 56 Raf MEK ERK 55 spontaneous preterm birth 55 HGPS 55 axillary dissection 55 sCJD 55 neoplasias 55 fetuin 55 carry BRCA mutation 55 bowel polyps 55 ductal lobular 55 gene APOE4 55 extracolonic 55 hyperemesis gravidarum 55 SHBG 55 mutated K ras 55 fetal chromosomal 55 unexplained infertility 55 GSTM1 55 mosaicism 55 coronary calcification 55 fetal microchimerism 55 untreated hypothyroidism 55 fetal malformations 55 adenomyosis 55 Rh factor 55 missense mutations 55 Cristofanilli 55 precancerous condition 55 AAT deficiency 55 BRCA2 genes 55 multivariable adjusted 55 prolonged QT interval 55 Male infertility 55 homozygotes 55 intravenous bisphosphonates 55 Premature menopause 55 gene mutation 55 endometriosis ovarian cysts 55 mutation 55 aneuploidies 55 sex hormone estrogen 55 dose ionizing radiation 55 pre menopausal 55 Hip fracture 55 HER2 gene 55 asymptomatic hypothyroidism 55 abnormal Pap smear 55 inherited gene mutation 55 MC1R 55 Androgen deprivation therapy 55 Premenopausal 55 abnormal pap smear 55 lymph node removal 55 recurrent VTE 55 chromosomal mutations 55 serous ovarian cancer 55 pancreatic prostate 55 histological subtype 55 endometrial biopsy 55 OPRM1 gene 55 seminoma 55 premenstrual syndrome PMS 55 Subgroup analyzes 55 benign proliferative breast 55 systemic lupus erythematosus SLE 55 #.#ng/ml 55 thyroid deficiency 55 cranial irradiation 55 BMI percentile 55 node metastases 55 CMV antibodies 55 congenital toxoplasmosis 55 axillary lymph nodes 55 Gestational diabetes 55 myelomeningocele 55 EGFR mutation 55 colorectal neoplasms 55 VCUG 55 chromosome abnormalities 55 polycystic ovarian syndrome 55 conditional logistic regression 55 estrogen receptor positive 55 genetic polymorphisms 55 System IPSS 55 impair fertility 55 precancerous cervical lesions 55 shorter telomere length 55 thyrotropin 55 breast lesions 55 mutated BRAF gene 55 dietary calcium intake 55 hyperandrogenism 55 molar pregnancy 55 prostate carcinoma 55 basal cell nevus syndrome 55 autoantibodies 55 gestational hypertension 55 abnormal mammograms 55 serum PTH 55 Soy isoflavones 55 BRCA testing 55 uterine cancers 55 abnormal cytology 55 renal carcinoma 55 CYP #D# 55 microdeletions 55 NR#A# gene 55 carotid IMT 55 VUR 55 HBsAg 55 LHRH receptor positive 55 polyomavirus nephropathy 55 Epstein Barr virus EBV 55 Peutz Jeghers syndrome 55 BRAF V#E mutation 55 hormones progesterone 55 breast lobules 55 circulating estrogens 55 TOMM# 55 nulliparous 55 herpesviruses 55 DNA methylation patterns 55 epigenetic changes 55 telomere lengths 55 FMR1 gene 55 distant metastases 55 hamartoma 55 proband 55 CVD mortality 55 metastatic prostate 55 Ovarian cysts 55 Oestrogen 55 chromosomal abnormalities 55 genital lesions 55 HER2 negative 55 Premature ejaculation 55 rs# [001] 55 basal cell carcinoma BCC 55 invasive cervical cancer 55 Rh positive 55 apoE 55 polyp recurrence 55 Estrogen therapy 54 adiponectin levels 54 BMPR2 54 adenoma 54 PCa 54 autoantibody positive 54 peritoneal carcinomatosis 54 asymptomatically 54 SORL1 54 hereditary breast 54 oncogenic HPV 54 neurologic complications 54 muscle dysmorphia 54 postoperative delirium 54 psychiatric comorbidities 54 urothelial cancer 54 heterozygotes 54 HIV seronegative 54 Apert syndrome 54 SLC#A# [002] 54 germline mutation 54 T1DM 54 ambiguous genitalia 54 CYP#C# gene 54 faulty BRCA genes 54 autosomal recessive disease 54 anaplastic lymphoma kinase 54 urine albumin 54 Rh incompatibility 54 atherosclerotic lesions 54 chlamydia infection 54 situ LCIS 54 ERCC1 54 axillary nodes 54 heterotaxy 54 hydroxyvitamin D levels 54 undergo radical prostatectomy 54 rs# [002] 54 postmenopausal hormone replacement 54 lymphomas leukemias 54 2 diabetes T2D 54 incomplete revascularization 54 follicle stimulating hormone FSH 54 undergoing hysterectomy 54 preterm delivery 54 heterozygous 54 FTO variant 54 premenopausal 54 underarm lymph nodes 54 abdominal ultrasounds 54 hormone hCG 54 taxane therapy 54 estrogen progesterone 54 ovarian uterine 54 CMV infection 54 HLA B# 54 autistic traits 54 endometrial cancer 54 phthalate exposure 54 HER2 positivity 54 clinically insignificant 54 defective gene 54 androgen deficiency 54 renal cell carcinomas 54 Hutchinson Gilford progeria 54 transferrin saturation 54 liver metastasis 54 HIV seropositive 54 PAP smear 54 CYP#C# [001] 54 TRAF1 C5 54 troponin T 54 rs# [004] 54 folate intake 54 malignant neoplasm 54 contralateral breast 54 teratogens 54 progesterone receptor PR 54 Maternal obesity 54 galactosemia 54 Leydig cells 54 endocrine therapies 54 orchitis 54 Postpartum psychosis 54 hepatocellular carcinomas 54 abnormal lipid levels 54 gene mutations 54 HPV genotypes 54 serum selenium 54 prophylactic oophorectomy 54 gene variant 54 metastatic gastric 54 PSA velocity 54 impaired insulin secretion 54 progestins 54 breast asymmetry 54 orofacial clefts 54 gene variants 54 colorectal cancer CRC 54 extracolonic findings 54 Leydig cell 54 pancreatic endocrine 54 metastatic lymph nodes 54 induce ovulation 54 HbF 54 DEC2 54 abnormal lipid 54 ductal carcinomas 54 Genetic variants 54 genes predisposing 54 Hepatitis B virus 54 unmeasured confounding 54 microdeletion 54 tumor subtypes 54 PCA3 scores 54 organophosphate exposure 54 MIF protein 54 prophylactic mastectomies 54 de novo mutations 54 Uterine fibroids 54 genetic variants associated 54 familial adenomatous polyposis 54 serum IgE 54 aneuploidy screening 54 syngeneic 54 pelvic ultrasound 54 GBA mutations 54 bladder cancers 54 LRP5 54 tibolone 54 vaginal cancers 54 histologic subtype 54 Screening mammography 54 PAP smears 54 ovulatory dysfunction 54 hereditary nonpolyposis colorectal cancer 54 latent TB infection 54 colorectal carcinoma 54 singleton pregnancies 54 homozygous 54 COMT gene 54 Prostate Specific Antigen PSA 54 pre cancerous lesion 54 uterine perforation 54 CYP#D# 54 postoperative pulmonary 54 undergone hysterectomies 54 B7 H3 54 genital human papillomavirus 54 immuno compromised individuals 54 BCG vaccinated 54 cisplatin resistant 54 NOMID 54 subfertility 54 AUDs 54 plasma folate 54 HER2 neu 54 CGG repeats 54 oral contraceptives OCs 54 carotid stenosis 54 Cowden syndrome 54 cardioembolic stroke 54 fructose intolerance 54 leiomyomas 54 breast uterine 54 atypical ductal hyperplasia 54 Pap smear screening 54 sentinel nodes 54 Polycystic ovary syndrome 54 pelvic malignancies 54 recessive mutations 54 transfusion syndrome 54 neonatal morbidity 54 hypermethylated 54 tumor subtype 54 pAkt 54 invasive ductal 54 SORL1 gene 54 serum testosterone levels 54 APOE epsilon 4 54 anal HPV 54 JAK mutations 54 psychiatric comorbidity 54 sFlt 1 54 chromosomal anomalies 54 monoclonal gammopathy 54 Postnatal depression 54 metabolize carbohydrates 54 HLA DQ2 54 congenital anomalies 54 denser breasts 54 axillary lymph node 54 placenta accreta 54 Gynecologists recommends 54 overt hypothyroidism 53 prognostic indicator 53 ovarian tumors 53 undescended testes 53 ultra rapid metabolizer 53 undergoing radical prostatectomy 53 N. gonorrhoeae 53 prostate carcinogenesis 53 microsatellite instability 53 undergone bariatric surgery 53 behavioral disinhibition 53 test FOBT 53 lobular 53 nodal metastases 53 MCADD 53 Li Fraumeni syndrome 53 mammographic breast density 53 IUGR 53 gallstone formation 53 cervical vaginal 53 p# activation 53 allele 53 susceptibility gene 53 ovarian carcinoma 53 malignant lesions 53 M. pneumoniae 53 spontaneous preterm delivery 53 mucinous 53 hormonal abnormalities 53 MC1R gene 53 androgenic hormones 53 SHANK3 53 incidentalomas 53 late onset hypogonadism 53 pancreatic adenocarcinoma 53 KRAS mutation 53 faulty BRCA1 gene 53 Previous epidemiological studies 53 Genital herpes 53 Acute myeloid leukemia 53 HER2 amplification 53 ATG#L# 53 Apolipoprotein E4 53 FUS protein 53 pancreatic lung 53 cervical lymph nodes 53 Thyroid nodules 53 Polycystic Ovary Syndrome 53 airway responsiveness 53 dysfunctional voiding 53 Malignant mesothelioma 53 thyroid nodules 53 cyclin E 53 mammographically 53 BRCA deficient 53 APOE 53 CNTNAP2 53 sonographic diagnosis 53 drank colas 53 HPV# 53 nonsmall cell lung cancer 53 multivariate adjustment 53 androgen receptor gene 53 obese postmenopausal 53 HIV HCV coinfected 53 nonfasting triglyceride levels 53 hypogonadotropic hypogonadism 53 adrenal cortex 53 TNF blocker therapy 53 chromosomal anomaly 53 EBV infection 53 p# Shc 53 spontaneous mutations 53 selenium intake 53 Premenopausal women 53 diagnosed prenatally 53 PCNSL 53 micrometastases 53 TP# gene 53 invasive breast cancer 53 BRAF V#E 53 uterus fallopian tubes 53 clinically localized prostate 53 disease NAFLD 53 serum IGF 53 insulin resistance syndrome 53 lymph node metastasis 53 amenorrhoea 53 TOP2A gene 53 pre cancerous polyps 53 CYP#A# gene 53 LungAlert TM 53 DISC1 gene 53 colorectal cancer incidence 53 fetal abnormalities 53 mutated BRCA 53 prolapsed uterus 53 endoxifen 53 cTnT 53 nonischemic 53 bronchopulmonary dysplasia 53 Glioblastoma multiforme GBM 53 body fatness 53 R#W [002] 53 Schaffir 53 premature ovarian 53 GSTP1 53 perimenopausal women 53 cancerous polyps 53 mammary tumors 53 p# protein 53 male hormone androgen 53 immunocompetent 53 sporadic ALS 53 GBM tumors 53 male hormones androgens 53 cervicitis 53 invasive ductal breast cancer 53 hormone estradiol 53 Pelvic inflammatory 53 post natally 53 normal karyotype 53 herpes infection 53 PON1 enzyme 53 enterovirus infection 53 drank decaffeinated coffee 53 beta carotene supplementation 53 recessive genetic 53 androgen signaling 53 Testicular cancer 53 FMRP protein 53 NPM1 mutations 53 IDH mutations 53 cytologic 53 genes BRCA 53 Follicle Stimulating Hormone FSH 53 seronegative 53 rs# [003] 53 osteosarcomas 53 choline intake 53 serum GGT 53 ZNF# 53 supratentorial 53 inherit predisposition 53 neuropsychological impairments 53 uterine tumors 53 proximal colon 53 densest breasts 53 diabetes mellitus DM 53 Polycystic ovary syndrome PCOS 53 neoadjuvant therapy 53 euthyroid 53 medulloblastoma tumors 53 hormone androgen 53 adrenal function 53 somatic mutations 53 acute myelogenous leukemia AML 53 corticosterone levels 53 chromosomal instability 53 colorectal polyps 53 asymptomatic bacteriuria 53 5 HTTLPR 53 neurodevelopmental impairment 53 GH deficiency 53 gastric adenocarcinoma 53 invasive prenatal 53 seropositivity 53 hormone receptor status 53 tamoxifen Nolvadex ® 53 gastric carcinoma 53 invasive lobular carcinoma 53 estrogen receptor 53 CFTR gene 53 CALHM1 53 sulphonylureas 53 latent tuberculosis infection 53 glandular tissue 53 spontaneously aborted 53 hypopituitarism 53 Epidemiologic studies 53 breast cancers 53 IDH1 mutation 53 homozygosity 53 peripartum cardiomyopathy 53 Osteoporotic fractures 53 monogenic 53 abnormal Pap tests 53 varicella infection 53 ductal 53 neurocognitive impairment 53 GBV C 53 TMEM#B 53 recessive genes 53 Testosterone gel 53 urolithiasis 53 microscopic hematuria 53 polycystic ovarian disease 53 MC4R gene 53 reproductive abnormalities 53 immunodeficient 53 Pelvic Inflammatory Disease 53 Genetic mutations 53 MLL2 53 overexpress HER2 53 cryptorchidism 52 chromosome abnormality 52 precocious puberty 52 PIK3CA 52 HIV uninfected 52 TRAIL induced apoptosis 52 abnormal pap 52 Her2 positive 52 Oral contraceptives 52 MCAD deficiency 52 CYP#C# * 52 precancers 52 vasa previa 52 deCODE ProstateCancer TM 52 PCOD 52 G6PD deficiency 52 Smac mimetic 52 COPEGUS therapy 52 atherosclerotic lesion 52 ano genital warts 52 neurofibromas 52 mesotheliomas 52 Enlarged prostate 52 obstructive CAD 52 Personality traits 52 antibody titer 52 breast cancer metastasis 52 testosterone secretion 52 HPV subtypes 52 neuroblastomas 52 HLA gene variant 52 underactive thyroid gland 52 Fatty liver 52 Hurler syndrome 52 asymptomatic PAD 52 abdominally obese 52 hematopoietic cancers 52 IL#R 52 ABCB1 gene 52 phthalate metabolites 52 nonvertebral fracture 52 BRAF mutations 52 vulvar cancers 52 fibrocystic changes 52 Zinc deficiency 52 karyotypes 52 adiponectin concentrations 52 mitochondrial toxicity 52 Sexual dysfunction 52 gene predisposing 52 gamma globin gene 52 monozygotic twins 52 genomic alterations 52 nonseminoma 52 familial ALS 52 Breastfed infants 52 Preterm babies 52 bacterial vaginosis 52 folate deficiency 52 Genital HPV 52 p#INK#a 52 lipid abnormalities 52 genetic variant 52 haemochromatosis 52 hormone FSH 52 unprotected vaginal 52 colonic polyps 52 subclinical disease 52 MSMB 52 urinary bladder cancer 52 SMN protein 52 accomplice Hudgens 52 epithelial ovarian 52 undescended testicles 52 HLA molecules 52 preventive mastectomy 52 clade B 52 Prostatitis 52 cervical neoplasia 52 Sexually active 52 malignant polyps 52 HER2 ErbB2 52 endometrial cells 52 endometrial ovarian 52 potentially hepatotoxic 52 fibrocystic breasts 52 urethritis 52 colorectal tumor 52 malignant prostate 52 vasomotor symptoms 52 beta thalassemia 52 anovulatory 52 sodium valproate 52 estrogen progestin therapy 52 Genetic mutation 52 preoperative chemotherapy 52 LRRK2 gene 52 oesophageal adenocarcinoma 52 Akt1 52 Fetal heartbeats 52 estrogen receptors 52 loop diuretics 52 testicular dysgenesis syndrome 52 ALND 52 multivariable Cox 52 thromboembolism 52 causative gene 52 undergo mastectomy 52 malignant transformation 52 HER2 receptors 52 phytoestrogen intake 52 folate supplementation 52 PARP inhibition 52 sarcomatoid 52 cervix uteri 52 abnormal chromosomes 52 osteopenic 52 EGFR mutation status 52 Uncontrolled hypertension 52 perimenopausal 52 HBeAg negative 52 KIBRA 52 etiologic 52 anti androgen 52 allelic variants